Circulating miR-221/222 expression as microRNA biomarker predicting tamoxifen treatment outcome: a case–control study

The high mortality rate in breast cancer (BC) patients is generally due to metastases resistant to systemic therapy. Two causes of systemic therapy resistance in BC patients are circulating miRNAs-221 and miR-222, leading to improved BC cell proliferation, survival, and reduced cell apoptosis. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Patellongi, Ilhamjaya, Amiruddin, Alfiah, Massi, Muhammad N., Islam, Andi A., Pratama, Muhammad Y., Sutandyo, Noorwati, Latar, Nani H.M., Faruk, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406100/
https://www.ncbi.nlm.nih.gov/pubmed/37554919
http://dx.doi.org/10.1097/MS9.0000000000001061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406100/
https://www.ncbi.nlm.nih.gov/pubmed/37554919
http://dx.doi.org/10.1097/MS9.0000000000001061

Ejemplares similares